Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.72K 71.35K 65.47K 123K 8.41M 125K 847K 331K 4.14M 328K 321K 14.3M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 201M 184M 346M 23.67B 351M 2.38B 931M 11.63B 923M 903M 40.23B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.44%+1.19%+26.20%+52.36% 364.3B
Weighted average by Cap. +0.76%+1.95%+35.99%+78.15%

Financials

2016 2017
Net sales 54.27M 47.67M 44.33M 40.68M 76.43M 5.23B 77.61M 526M 206M 2.57B 204M 199M 8.88B 106M 93.05M 86.54M 79.41M 149M 10.2B 152M 1.03B 401M 5.02B 398M 389M 17.34B
Net income -103M -90.45M -84.11M -77.18M -145M -9.92B -147M -999M -390M -4.88B -387M -378M -16.86B -125M -110M -102M -93.84M -176M -12.06B -179M -1.21B -474M -5.93B -470M -460M -20.5B
Net Debt 209M 184M 171M 157M 295M 20.17B 300M 2.03B 794M 9.92B 786M 770M 34.29B 246M 216M 201M 184M 346M 23.66B 351M 2.38B 931M 11.63B 922M 902M 40.21B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock